Antimicrobial peptides (AMPs), or host defence peptides, are short proteins in various life
forms. Here we discuss AMPs, which may become a promising substitute or adjuvant in …

Dalbavancin is a novel, long-acting lipoglycopeptide characterized by a long elimination half-
life coupled with excellent in vitro activity against multidrug-resistant Gram-positives …

Background Osteomyelitis is a challenging infection that can involve 4–6 weeks of
intravenous (IV) antibiotics. Dalbavancin, approved for acute bacterial skin and skin …

Dalbavancin, a lipoglycopeptide with prolonged half-life approved for the treatment of acute
bacterial skin and soft tissue infections, can be used for the treatment of infections caused by …

Objectives To analyse the effectiveness of dalbavancin (DBV) in clinical practice as
consolidation therapy in patients with bloodstream infection (BSI) and/or infective …

Antimicrobial resistance (AMR) remains one of the top public health issues of global
concern. Among the most important strategies for AMR control there is the correct and …

Introduction Dalbavancin is approved for acute bacterial skin and skin structure infections
(ABSSSIs) but offers a potential treatment option for complicated invasive gram-positive …

Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive
microorganisms, a long half-life, a favorable safety profile, and a high concentration in bone …

Infections caused by Gram-positive bacteria are a major public health problem due to their
increasing resistance to antibiotics. Staphylococcus and Enterococcus species' resistance …

Staphylococcus aureus (S. aureus) is a pathogen responsible for various community and
hospital-acquired infections with life-threatening complications like bacteraemia …